IL37 and psoriasis: Similar data indicate that rosmarinic acid reduces IL-23 production, suppresses Th17-dominated inflammation, and down-regulates the Jak2/Stat3 signal pathway, suppressing psoriasis-like skin inflammation in vivo and in vitro.